Roger Farah Named Executive Chairman of the Board Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.
05 to $1.10 WOONSOCKET, R.I.
, Oct. 18, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS ) today announced that David Joyner was appointed President and Chief Executive Officer, effective October 17 , replacing Karen Lynch , who stepped down from her position in agreement with the company's Board of Directors. Joyner also joined the Board of Directors.
In addition, current Chairman of the Board, Roger Farah , will now be Executive Chairman. Joyner was most recently executive vice president, CVS Health, and president, CVS Caremark. He led the pharmacy services business, which provides solutions to employers, health plans and government entities and serves approximately 90 million members through Caremark, CVS Specialty, and other areas.
Joyner has 37 years of health care and pharmacy benefit management experience, and has also served on the boards of several private equity-backed health care companies. He began his career at Aetna as an employee benefit representative before joining Caremark Prescription Services as a regional sales manager. He then served as executive vice president of sales and account services at CVS Caremark and executive vice president of sales and marketing at CVS Health.
"The Board believes this is the right time to make a change, and we are confident that David is the rig.
